Isracann Biosciences Provides Bi-Weekly Default Status Report
13 oct. 2022 08h30 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that further to its news release dated...